Effexor Patent Valid & Infringed

CaseSigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2010] FCA 1211

Judge: Jagot J

In this case, a patent for a sustained release formulation of Effexor was found valid and infringed.  While a number of different aspects were covered, I found the discussions concerning inventive step most useful. I have distilled some points and lessons.  The cross examinations of the witnesses are worth reading.

Inventive step notes:

  1. Detailed laboratory notebooks can be used to establish a finding of inventive step.
  2. Reference to a result can define a claim.  The question is what the skilled addressee would have understood at the priority date by the reference to the result.
  3. A finding that experiments performed are of a routine character that would be tried as a matter of course by the skilled addressee would support a holding of obviousness.
  4. A witness's use of hindsight undermines an allegation of inventive step.
  5. A witness's knowledge that an invention has been successful indicates the use of hindsight.
  6. A witness's reference to publications not available at the priority date indicates the use of hindsight.
  7. Knowledge of the existence of a patent dispute can cast doubt on the reliability of a witness's evidence.
  8. The problem and solution approach could be unfair to an inventor of a combination or a simple solution.
  9. Inventive step may be lacking if the available information at the priority date would support the existence of a motivation to prepare a formulation in question.


  1. Not only R&D teams, but all inventors should keep a careful developmental record in a form that can be readily reproduced.
  2. Where possible, witnesses should not be made aware of the patent dispute or even of the existence of a patent.
  3. Witnesses must be made to understand the importance of preparing their material as at the priority date, otherwise stated.


Popular posts from this blog

Amending Granted Patents

For the Record

Invention copied? That's a good thing